Abraham H. Dachman to Antibodies, Monoclonal
This is a "connection" page, showing publications Abraham H. Dachman has written about Antibodies, Monoclonal.
Connection Strength
0.011
-
Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer. J Clin Oncol. 2005 Nov 01; 23(31):8033-40.
Score: 0.011